We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$73.9B
AUM Growth
+$5.6B
Cap. Flow
-$3.28B
Cap. Flow %
-4.43%
Top 10 Hldgs %
14.52%
Holding
790
New
69
Increased
319
Reduced
276
Closed
94

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$683M
2
META icon
Meta Platforms (Facebook)
META
+$428M
3
SLB icon
SLB Ltd
SLB
+$322M
4
D icon
Dominion Energy
D
+$239M
5
AZO icon
AutoZone
AZO
+$237M

Sector Composition

Rank Sector Weight
1 Financials 19.15%
2 Healthcare 17.66%
3 Industrials 15.13%
4 Technology 13.58%
5 Consumer Discretionary 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
451
Apple
AAPL
$4.97T
$1.99M ﹤0.01%
15,278
+750
+5% +$107K
ECPG icon
452
Encore Capital Group
ECPG
$2.01B
$1.96M ﹤0.01%
+40,829
New +$1.97M
LEN icon
453
Lennar Class A
LEN
$20.4B
$1.92M ﹤0.01%
24,142
+4,528
+23% +$367K
PFC
454
DELISTED
Premier Financial Corp. Common Stock
PFC
$1.89M ﹤0.01%
70,252
-244
-0.3% -$6.82K
BERY
455
DELISTED
Berry Global Group, Inc.
BERY
$1.78M ﹤0.01%
32,010
+740
+2% +$36.3K
AL
456
DELISTED
Air Lease Corp
AL
$1.76M ﹤0.01%
+45,928
New +$1.65M
BSX icon
457
Boston Scientific
BSX
$68.4B
$1.76M ﹤0.01%
38,092
-19,496
-34% -$844K
BRX icon
458
Brixmor Property Group
BRX
$9.72B
$1.75M ﹤0.01%
77,396
-620
-0.8% -$13.3K
QIPT
459
DELISTED
Quipt Home Medical
QIPT
$1.74M ﹤0.01%
370,186
+81,802
+28% +$357K
SMRT icon
460
SmartRent
SMRT
$192M
$1.72M ﹤0.01%
707,419
+664,731
+1,557% +$1.64M
HST icon
461
Host Hotels & Resorts
HST
$17.5B
$1.71M ﹤0.01%
106,618
-1,608
-1% -$28.1K
HSIC icon
462
Henry Schein
HSIC
$9.78B
$1.7M ﹤0.01%
21,289
+491
+2% +$37.2K
HROW icon
463
Harrow
HROW
$1.44B
$1.69M ﹤0.01%
114,693
+2,653
+2% +$31.7K
AGX icon
464
Argan
AGX
$6.9B
$1.68M ﹤0.01%
45,573
-206
-0.4% -$7.25K
SPGI icon
465
S&P Global
SPGI
$124B
$1.67M ﹤0.01%
4,981
-678
-12% -$223K
UBS icon
466
UBS Group
UBS
$170B
$1.64M ﹤0.01%
87,692
-42,522
-33% -$723K
CACI icon
467
CACI
CACI
$10.8B
$1.63M ﹤0.01%
5,424
+104
+2% +$30.3K
CAKE icon
468
Cheesecake Factory
CAKE
$5.03B
$1.6M ﹤0.01%
50,319
+28,256
+128% +$944K
ELS icon
469
Equity Lifestyle Properties
ELS
$13.1B
$1.59M ﹤0.01%
+24,652
New +$1.56M
INVA icon
470
Innoviva
INVA
$1.6B
$1.58M ﹤0.01%
119,414
+29,810
+33% +$392K
VTV icon
471
Vanguard Value ETF
VTV
$188B
$1.57M ﹤0.01%
11,150
+7,782
+231% +$1.07M
PRDO icon
472
Perdoceo Education
PRDO
$2.17B
$1.56M ﹤0.01%
111,900
+9,496
+9% +$121K
INMD icon
473
InMode
INMD
$871M
$1.54M ﹤0.01%
139,073
+109,459
+370% +$3.81M
LMT icon
474
Lockheed Martin
LMT
$131B
$1.51M ﹤0.01%
3,113
+72
+2% +$33.5K
KB icon
475
KB Financial Group
KB
$39.5B
$1.48M ﹤0.01%
38,355
+929
+2% +$33.5K

Similar funds

Boston Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Boston Partners held 790 positions worth $73.9B, up 8.2% from $68.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Partners withdrew a net $3.28B in Q4 2022, closing 94 positions and reducing 276 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $428M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Boston Partners opened a new position in Prologis worth $156M.

  • Boston Partners's largest Q4 2022 buy was Prologis: 1,379,952 shares worth $156M.
  • Boston Partners added most to Bristol-Myers Squibb in Q4 2022, an estimated $274M increase.
  • Boston Partners's biggest Q4 2022 reduction was ConocoPhillips, cutting an estimated $683M.
  • Boston Partners fully exited Meta Platforms (Facebook) in Q4 2022, selling an estimated $428M.
  • Boston Partners's ten largest holdings make up 15% of its $73.9B portfolio in Q4 2022.
  • Boston Partners opened 69 new positions and closed 94 in Q4 2022.
  • Boston Partners's portfolio value rose 8.2% quarter-over-quarter to $73.9B.

Based on Boston Partners's 13F filing for Q4 2022, filed 8 Feb 2023.